AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 213 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $956,362 | -20.6% | 20,795 | -0.7% | 0.53% | -14.2% |
| Q2 2023 | $1,204,111 | -61.0% | 20,952 | -74.5% | 0.61% | -64.4% |
| Q1 2023 | $3,084,488 | +35.4% | 82,253 | +1.2% | 1.72% | +21.9% |
| Q4 2022 | $2,277,662 | +0.8% | 81,287 | +1.1% | 1.41% | -6.7% |
| Q3 2022 | $2,259,000 | +75.0% | 80,399 | +116.6% | 1.52% | +84.8% |
| Q2 2022 | $1,291,000 | +6.4% | 37,117 | +9.8% | 0.82% | +32.9% |
| Q1 2022 | $1,213,000 | – | 33,794 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LAM GROUP, INC. | 130,250 | $3,649,605 | 3.75% |
| SHAKER INVESTMENTS LLC/OH | 81,287 | $2,277,662 | 1.41% |
| Mesirow Institutional Investment Management, Inc. | 374,414 | $10,491,080 | 1.38% |
| OBERWEIS ASSET MANAGEMENT INC/ | 134,000 | $3,754,680 | 0.80% |
| Portolan Capital Management | 270,791 | $7,587,564 | 0.75% |
| Hillsdale Investment Management Inc. | 172,238 | $4,826,109 | 0.41% |
| Capital Impact Advisors, LLC | 14,669 | $411,025 | 0.40% |
| Watershed Asset Management, L.L.C. | 9,555 | $267,731 | 0.34% |
| Quantedge Capital Pte Ltd | 35,153 | $984,987 | 0.33% |
| FEDERATED HERMES, INC. | 3,284,217 | $92,023,760 | 0.25% |